Medopad delivers first mHealth enterprise solution for iPad Pro

Royal Free London using Medopad to improve quality of patient care

Medopad has announced that Royal Free London NHS Foundation Trust is one of the first NHS organisations to deploy the iPad Pro equipped with Medopad’s enterprise mHealth solution.

Medical professionals can take full advantage of the iPad Pro’s capabilities, including the larger Retina display, high-resolution graphical advancements and powerful functionality of the Apple Pencil.

Doctors using Medopad’s solution have a centralised source of integrated patient data whenever required. This provides them with the ability to collaborate in real-time with colleagues without any need to return to multi-disciplinary team (MDT) spaces, computer stations or administrative offices. This enhanced mobility and flexibility helps increase staff productivity, reduce costs and improve the operational efficiency of the healthcare organisation.

Dr Rich Khatib, chief executive of Medopad, said: “Empowering medical employees and improving patient care is what drives Medopad to keep innovating. The iPad Pro offers a host of new possibilities for doctors. Hospitals such as the Royal Free are recognising the medical, operational and financial gains that are possible from using the latest developments in the field of mHealth.”

Specifically designed for use anywhere within the hospital environment, Medopad’s solution reflects Apple’s design simplicity. Highlights include:

  • Medical data, vitals, charts and patient imagery can be easily recalled, annotated, actioned and shared between colleagues in the hospital and across the world
  • The iPad Pro’s Split View enables side-by-side data comparisons and multi-tasking between Medopad’s solution and other installed medical applications
  • An enterprise-grade, CE-certified source medical data customised to each individual doctor, nurse, medical staff member and patient

Dan Vahdat, chief technology officer at Medopad, said: “The iPad Pro’s larger screen delivers imagery of the highest quality. This is a critical requirement for practitioners who must interpret complex medical charts, clinical images, scans and other critical documentation. We are excited for what this means for both patients and doctors.”

This news completes a year of landmark developments for Medopad. In April, the company launched its new patient monitoring solutions at NHS London’s King’s College Hospital, which is now live in the majority of London’s teaching hospitals.

Companies